02/28
Headlines

Finance

Basic Material Active runners: Exxon Mobil (NYSE:XOM), Chesapeake Energy (NYSE:CHK), Kinross Gold (NYSE:KGC), Petroleo Brasileiro Petrobras (NYSE:PBR)

Kristen Barton02 mins

Exxon Mobil Corporation (NYSE:XOM), the world’s largest publicly traded oil company, has agreed to disclose more information about the environmental risks of hydraulic fracturing, the process known as fracking. In an agreement with New York City’s pension funds, which control Exxon Mobile Corporation (NYSE:XOM) shares worth roughly $1.02 billion, the company agreed to report on…

Read More

Biotech Runners: MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), CytRx Corporation (NASDAQ:CYTR)

Adam Keintzel02 mins

MannKind Corporation (NASDAQ:MNKD) had its price objective reduced by Cowen and Company from $5.50 to $5.00 in a report released on Wednesday,Stock Ratings News reports. Analysts at Piper Jaffray downgraded shares of MannKind Corporation (NASDAQ:MNKD) from a neutral rating to an underweight rating in a research note on Monday. MannKind Corporation (NASDAQ:MNKD) stock performance was…

Read More

Biotech Volatile Stocks: NewLink Genetics Corp (NASDAQ:NLNK), Alnylam Pharmaceuticals (NASDAQ:ALNY), Kindred Biosciences (NASDAQ:KIN), Agenus (NASDAQ:AGEN)

John Bellich02 mins

NewLink Genetics Corp (NASDAQ:NLNK)’s algenpantucel-L is expected to garner the highest sales and will be launched in both resectable and unresectable locally-advanced settings. Other drugs with significant forecast sales by 2017 include Threshold Pharmaceuticals/Merck’s TH-302 and Merrimack Pharmaceuticals’ MM-398,” director says. NewLink Genetics Corp (NASDAQ:NLNK) stock performance was -9.03% in last session and finished the…

Read More
FB Nasdaq FB Facebook

Biotech losers: ZIOPHARM Oncology (NASDAQ:ZIOP), Sangamo Biosciences (NASDAQ:SGMO), Lexicon Pharmaceuticals (NASDAQ:LXRX), XOMA Corp (NASDAQ:XOMA)

Colin Pettis02 mins

On Apr 3, Zacks Investment Research upgraded ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) to Zacks Rank #1 (Strong Buy). ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)’s loss estimates have declining on the back of better-than-expected fourth quarter 2013 results. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stock performance was -6.06% in last session and finished the day at $4.34. Traded volume was 1.86million…

Read More

Investor’s Alert: Sony Corporation (NYSE:SNE), Marvell Technology (NASDAQ:MRVL), Broadcom Corporation (NASDAQ:BRCM), Advanced Micro Devices (NYSE:AMD)

Adam Keintzel02 mins

PlayStation 4 creator Sony Corporation (ADR) (NYSE:SNE) is expected to tease its rendition of virtual reality technology during a Tuesday presentation called “Driving the Future of Innovation at Sony Computer Entertainment.” Sony Corporation (ADR) (NYSE:SNE) stock performance was -0.77% in last session and finished the day at $19.29. Traded volume was 1.44million shares in the…

Read More

Investor’s Watch List: Zillow Inc (NASDAQ:Z), Pacific Ethanol (NASDAQ:PEIX), Biogen Idec Inc (NASDAQ:BIIB), The Kroger Co. (NYSE:KR)

Jason Knox02 mins

Zillow, Inc. (NASDAQ:Z), the leading real estate information marketplace, today announced it entered into an exclusive partnership with Beijing Yisheng Leju Information Services Co. (“Leju”), an affiliate of E-House (China) Holdings Limited (NYSE: EJ), a leading real estate services company in China, to power Leju’s U.S. home shopping experience. Zillow Inc (NASDAQ:Z) stock performance was…

Read More